South America Prostate Cancer Nuclear Medicine Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South America Prostate Cancer Nuclear Medicine Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South America Prostate Cancer Nuclear Medicine Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South America Prostate Cancer Nuclear Medicine Market Regional Analysis

6.2 South America Prostate Cancer Nuclear Medicine Market Revenue 2020-2028 (US$ Million)

6.3 South America Prostate Cancer Nuclear Medicine Market Forecast Analysis

7. South America Prostate Cancer Nuclear Medicine Market Analysis – by Type

7.1 PET

7.1.1 Overview
7.1.2 PET: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 SPECT

7.2.1 Overview
7.2.2 SPECT: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. South America Prostate Cancer Nuclear Medicine Market Analysis – by PET Product

8.1 F-18

8.1.1 Overview
8.1.2 F-18: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 C-11

8.2.1 Overview
8.2.2 C-11: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Ga68-PSMA

8.3.1 Overview
8.3.2 Ga68-PSMA: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. South America Prostate Cancer Nuclear Medicine Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Clinics: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. South America Prostate Cancer Nuclear Medicine Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America

10.2.1 South America Prostate Cancer Nuclear Medicine Market Breakdown, by Key Country, 2023 and 2028 (%)
10.2.1.1 South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast Analysis – by Country
10.2.1.1 Brazil: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 Brazil: South America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
10.2.1.1.2 Brazil: South America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
10.2.1.1.3 Brazil: South America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

10.2.1.2 Argentina: South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Argentina: South America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
10.2.1.2.2 Argentina: South America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
10.2.1.2.3 Argentina: South America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

10.2.1.3 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
10.2.1.3.2 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
10.2.1.3.3 Rest of South and Central America : South America Prostate Cancer Nuclear Medicine Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 ImaginAb

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 ABX advanced biochemical compounds GmbH

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Telix Pharmaceuticals Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Lantheus Medical Imaging, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

South America Prostate Cancer Nuclear Medicine Market

Analysis – by Type (PET and SPECT), PET Product (F-18, C-11, and Ga68-PSMA), and End User (Hospitals, Clinics, and Others)